Understanding the benefits of risk-based optimization on clinical trial supply planning

“Risk-Based Optimization Or Clinical Supply Forecasting? The Impact On Clinical Trial Supply Planning”

Watch the replay

What You’ll Learn In This Webinar

  • Learn how to identify the differences between risk-based optimization and forecasting for clinical supply chain and manufacturing planning
  • Discover how clinical trial optimization can reduce drug waste & budgets, while achieving 100% service level and accelerated timelines
  • See real-life case studies demonstrating the impact of risk-based optimization vs. forecasting

About the Speakers

Amaury Jeandrain Head of Solutions Adoption, Life Sciences

Amaury Jeandrain is an expert in Clinical trial supply and manufacturing optimization. He started his career in clinical supply chain working for a CMO before joining N-SIDE. In his 5 years of experience at N-SIDE, Amaury supported the optimization of hundreds of trials and programs from different indications and pharmaceutical companies, providing services ranging from risk-based optimization to clinical trial design and solving drug supply shortage problems. Amaury now leads a group of consultants, focusing on the Adoption N-SIDE’s solutions.

Cyrille Lefevre - CLE
Cyrille Lefèvre Life Sciences Senior Expert

Cyrille Lefèvre has been working on the optimization of end-to-end clinical supplies with N-SIDE for more than 8 years. He has experience advising both large and small pharma for the forecasting and optimization of their clinical trials for all phases and through multiple therapeutic areas. Cyrille also has extensive experience training teams focusing on strategic planning and improving IRT resupply algorithms and the way they are used.

Watch the replay!